Adenoviral transduction of mesenchymal stem cells: In vitro responses and in vivo immune responses after cell transplantation

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Treacy, Oliver ^a   Ryan, Aideen E ^a   Heinzl, Teresa ^a   O'Flynn, Lisa ^a   Cregg, Marese ^a   Wilk, Mieszko ^a   Odoardi, Francesca ^b   Lohan, Paul ^a   O'Brien, Timothy ^a   Nosov, Mikhail ^a   Ritter, Thomas ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA MODIFICATION; GENE EXPRESSION PROFILING; GENE VECTOR; HELPER CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 84864708298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042662     Document Type: Article

References (38)

1. Bianco P, Riminucci M, Gronthos S, Robey PG, ((2001)) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. ((1999)) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
3. Barry FP, Murphy JM, ((2004)) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584.
4. Murphy JM, Fink DJ, Hunziker EB, Barry FP, ((2003)) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48: 3464-3474.
5. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, et al. ((2007)) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21: 1733-1738.
6. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. ((2008)) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586.
7. Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, et al. ((2007)) Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18: 2873-2882.
8. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, et al. ((2004)) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15: 1794-1804.
9. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J, ((2008)) Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 3: e2934.
10. Kumar S, Chanda D, Ponnazhagan S, ((2008)) Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15: 711-715.
11. Huang J, Zhang Z, Guo J, Ni A, Deb A, et al. ((2010)) Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 106: 1753-1762.
12. Griffin M, Greiser U, Barry F, O'Brien T, Ritter T, ((2010)) Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease. Discov Med 9: 219-223.
13. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ, ((2010)) Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 21: 1513-1526.
14. Edelstein ML, Abedi MR, Wixon J, ((2007)) Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 9: 833-842.
15. Cerullo V, Seiler MP, Mane V, Brunetti-Pierri N, Clarke C, et al. ((2007)) Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther 15: 378-385.
16. Zhang N, Schroppel B, Chen D, Fu S, Hudkins KL, et al. ((2003)) Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am J Transplant 3: 1230-1241.
17. Chen D, Ding Y, Schroppel B, Zhang N, Fu S, et al. ((2003)) Differential chemokine and chemokine receptor gene induction by ischemia, alloantigen, and gene transfer in cardiac grafts. Am J Transplant 3: 1216-1229.
18. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. ((2002)) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
19. Rasmusson I, ((2006)) Immune modulation by mesenchymal stem cells. Exp Cell Res 312: 2169-2179.
20. Nauta AJ, Fibbe WE, ((2007)) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
21. DelaRosa O, Lombardo E, ((2010)) Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm 2010: 865601.
22. Chuang CK, Wong TH, Hwang SM, Chang YH, Chen GY, et al. ((2009)) Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 17: 889-896.
23. Rooney GE, Moran C, McMahon SS, Ritter T, Maenz M, et al. ((2008)) Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate. Tissue Eng Part A 14: 681-690.
24. McMahon JM, Conroy S, Lyons M, Greiser U, O'Shea C, et al. ((2006)) Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 15: 87-96.
25. Shujia J, Haider HK, Idris NM, Lu G, Ashraf M, ((2008)) Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res 77: 525-533.
26. Tang J, Wang J, Zheng F, Kong X, Guo L, et al. ((2010)) Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 339: 107-118.
27. Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, et al. ((2011)) Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med.
28. Duffy GP, D'Arcy S, Ahsan T, Nerem RM, O'Brien T, et al. ((2010)) Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential. Tissue Eng Part A 16: 2755-2768.
29. Ritter T, Vogt K, Rieck P, Schilling-Schon A, Kolls J, et al. ((1999)) Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 69: 563-568.
30. Kolls J, Peppel K, Silva M, Beutler B, ((1994)) Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A 91: 215-219.
31. Ji JF, He BP, Dheen ST, Tay SS, ((2004)) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22: 415-427.
32. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, et al. ((2006)) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24: 1030-1041.
33. Basner-Tschakarjan E, Gaffal E, O'Keeffe M, Tormo D, Limmer A, et al. ((2006)) Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J Gene Med 8: 1300-1306.
34. Appledorn DM, Patial S, McBride A, Godbehere S, Van Rooijen N, et al. ((2008)) Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 181: 2134-2144.
35. Tan PH, Beutelspacher SC, Xue SA, Wang YH, Mitchell P, et al. ((2005)) Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105: 3824-3832.
36. Brandao JG, Scheper RJ, Lougheed SM, Curiel DT, Tillman BW, et al. ((2003)) CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine 21: 2268-2272.
37. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, et al. ((2007)) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109: 1422-1432.
38. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI, ((2001)) The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169: 12-20.